Mirmiran, Parvin
Hosseini, Shabnam
Bahadoran, Zahra
Azizi, Fereidoun
Article History
Received: 18 June 2022
Accepted: 18 January 2023
First Online: 20 January 2023
Declarations
:
: The study protocol was carried out according to the relevant guidelines expressed in the Declaration of Helsinki. Written informed consent was obtained from all participants. The ethics research council of the Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran, approved the study protocol (Ethics code: IR.SBMU.ENDOCRINE.REC.1401.020).
: Not applicable.
: Parvin Mirmiran, Shabnam Hosseini, and Fereidoun Azizi declare that they have no competing interests. Dr. Zahra Bahadoran is a member of the editorial board of BMC Endocrine Disorders.